MacroGenics Inc. Stock
MacroGenics Inc. Stock
MacroGenics Inc. took a tumble today and lost -€0.510 (-3.380%).
MacroGenics Inc. is currently one of the favorites of our community with 10 Buy predictions and no Sell predictions.
As a result the target price of 20 € shows a positive potential of 36.43% compared to the current price of 14.66 € for MacroGenics Inc..
For the coming years our community has positive and negative things to say abot the MacroGenics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Valuation (undervalued/overvalued)" there were negative voices in the community.
Pros and Cons of MacroGenics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of MacroGenics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
MacroGenics Inc. | -3.380% | -6.624% | 3.239% | 134.560% | 62.889% | -47.568% | - |
Ardelyx Inc. | 0.130% | -5.482% | -15.972% | 32.578% | 3.218% | -12.905% | - |
Salarius Pharmaceuticals Inc. | 4.250% | -0.935% | -18.462% | -68.120% | -23.604% | -98.261% | -99.994% |
Brainstorm Cell | 1.170% | -0.896% | -1.485% | -81.710% | 114.440% | -80.717% | - |
Comments
MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating.
Show more
Ratings data for MGNX provided by MarketBeat
MacroGenics, Inc. (NASDAQ: MGNX) had its price target raised by analysts at Barclays PLC from $12.00 to $23.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for MGNX provided by MarketBeat
MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $13.00 price target on the stock, up previously from $7.00.
Show more
Ratings data for MGNX provided by MarketBeat